no title
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Therapie - 75(2020), 5 vom: 15. Sept., Seite 513-514 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
No arguments for extra risk from ibuprofen in SARS-COV2 infection |
|---|
| Beteiligte Personen: |
Moore, Nicholas [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Inflammatory Agents, Non-Steroidal |
|---|
| Anmerkungen: |
Date Completed 14.12.2020 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.therap.2020.07.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314035451 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314035451 | ||
| 003 | DE-627 | ||
| 005 | 20231225151849.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.therap.2020.07.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1046.xml |
| 035 | |a (DE-627)NLM314035451 | ||
| 035 | |a (NLM)32829912 | ||
| 035 | |a (PII)S0040-5957(20)30130-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Moore, Nicholas |e verfasserin |4 aut | |
| 246 | 3 | 3 | |a No arguments for extra risk from ibuprofen in SARS-COV2 infection |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.12.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Ibuprofen | |
| 650 | 4 | |a SARS-CoV2 | |
| 650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
| 650 | 7 | |a Ibuprofen |2 NLM | |
| 650 | 7 | |a WK2XYI10QM |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Therapie |d 1947 |g 75(2020), 5 vom: 15. Sept., Seite 513-514 |w (DE-627)NLM000023655 |x 1958-5578 |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2020 |g number:5 |g day:15 |g month:09 |g pages:513-514 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.therap.2020.07.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2020 |e 5 |b 15 |c 09 |h 513-514 | ||